ADENURIC

This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug ADENURIC contains one active pharmaceutical ingredient (API):

1 Febuxostat UNII 101V0R1N2E - FEBUXOSTAT

Uric acid is the end product of purine metabolism in humans and is generated in the cascade of hypoxanthine → xanthine → uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase (XO). Febuxostat is a 2-arylthiazole derivative that achieves its therapeutic effect of decreasing serum uric acid by selectively inhibiting XO. Read about Febuxostat

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ADENURIC Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M04AA03	Febuxostat	M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production
Discover more medicines within M04AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10445R
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 05455113, 05455136, 05455142, 05455159, 10078397, 10078405, 10261256, 11015683, 11073835, 11073841, 11479721, 11853444, 11853450, 11893768, 13902980, 13902997, 13971857, 14227405, 14260561, 14260578, 14267103, 15373592, 15373600, 15529545, 15563134, 15563140, 17161322, 17161339, 17969225
Country: EE	Ravimiamet	Identifier(s): 1349287, 1349298, 1349300, 1349311, 1492961, 1492972, 1492983, 1492994, 1493007, 1493018, 1493029, 1493030
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08447001, 08447003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 101845, 168329
Country: FR	Base de données publique des médicaments	Identifier(s): 61871331, 64493890
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 170310, 170312, 299543, 374287, 376203, 381148, 381150
Country: IE	Health Products Regulatory Authority	Identifier(s): 65600, 65601, 65602
Country: IT	Agenzia del Farmaco	Identifier(s): 039538018, 039538032
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1032555, 1032556, 1032557, 1032558, 1063623, 1063624, 1063625, 1063626, 1063627, 1063628, 1063629, 1063630, 1079546, 1079547, 1079548, 1079549, 1079550, 1079551, 1079552, 1079553, 1079554, 1079555, 1079556, 1079557
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 101788, 101796
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15660, 15673
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100221962, 100221985
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W57781001, W57781002, W57781003, W57782001, W57782002, W57782003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699832090598, 8699832090604